Cargando...
Hydroxyurea for sickle cell anemia: What have we learned and what questions still remain?
PURPOSE OF REVIEW: Sickle cell anemia (SCA) is a well-characterized severe hematological disorder with substantial morbidity and early mortality. Hydroxyurea is a potent inducer of fetal hemoglobin, and evidence over the past 25 years has documented its laboratory and clinical efficacy for both adul...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181131/ https://ncbi.nlm.nih.gov/pubmed/21372708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e32834521dd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|